73 related articles for article (PubMed ID: 38691604)
1. CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.
Himeda CL; Jones TI; Jones PL
Mol Ther; 2016 Mar; 24(3):527-35. PubMed ID: 26527377
[TBL] [Abstract][Full Text] [Related]
2. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
Richards M; Coppée F; Thomas N; Belayew A; Upadhyaya M
Hum Genet; 2012 Mar; 131(3):325-40. PubMed ID: 21984394
[TBL] [Abstract][Full Text] [Related]
3. Exchange of subtelomeric regions between chromosomes 4q and 10q reverts the FSHD genotype and phenotype.
Ma Y; Schwager Karpukhina A; Dib C; Gautier C; Hermine O; Allemand E; Vassetzky YS
Sci Adv; 2024 May; 10(18):eadl1922. PubMed ID: 38691604
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.
Zeng W; Chen YY; Newkirk DA; Wu B; Balog J; Kong X; Ball AR; Zanotti S; Tawil R; Hashimoto N; Mortazavi A; van der Maarel SM; Yokomori K
Hum Mutat; 2014 Aug; 35(8):998-1010. PubMed ID: 24838473
[TBL] [Abstract][Full Text] [Related]
5. The Facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure.
Rossi M; Ricci E; Colantoni L; Galluzzi G; Frusciante R; Tonali PA; Felicetti L
BMC Med Genet; 2007 Mar; 8():8. PubMed ID: 17335567
[TBL] [Abstract][Full Text] [Related]
6. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
Banerji CRS; Zammit PS
EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
[TBL] [Abstract][Full Text] [Related]
7. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
Lemmers RJ; Wohlgemuth M; van der Gaag KJ; van der Vliet PJ; van Teijlingen CM; de Knijff P; Padberg GW; Frants RR; van der Maarel SM
Am J Hum Genet; 2007 Nov; 81(5):884-94. PubMed ID: 17924332
[TBL] [Abstract][Full Text] [Related]
8. Deciphering D4Z4 CpG methylation gradients in fascioscapulohumeral muscular dystrophy using nanopore sequencing.
Butterfield RJ; Dunn DM; Duval B; Moldt S; Weiss RB
Genome Res; 2023 Sep; 33(9):1439-1454. PubMed ID: 37798116
[TBL] [Abstract][Full Text] [Related]
9. Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target.
Heher P; Ganassi M; Weidinger A; Engquist EN; Pruller J; Nguyen TH; Tassin A; Declèves AE; Mamchaoui K; Banerji CRS; Grillari J; Kozlov AV; Zammit PS
Redox Biol; 2022 May; 51():102251. PubMed ID: 35248827
[TBL] [Abstract][Full Text] [Related]
10. Lipid droplets contribute myogenic differentiation in C2C12 by promoting the remodeling of the acstin-filament.
Tan Y; Jin Y; Zhao P; Wu J; Ren Z
Cell Death Dis; 2021 Nov; 12(12):1102. PubMed ID: 34815388
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy.
Karpukhina A; Galkin I; Ma Y; Dib C; Zinovkin R; Pletjushkina O; Chernyak B; Popova E; Vassetzky Y
Redox Biol; 2021 Jul; 43():102008. PubMed ID: 34030118
[TBL] [Abstract][Full Text] [Related]
12. Control of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Cancer.
Karpukhina A; Tiukacheva E; Dib C; Vassetzky YS
Trends Mol Med; 2021 Jun; 27(6):588-601. PubMed ID: 33863674
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 10q-linked FSHD identifies
Lemmers RJLF; van der Vliet PJ; Blatnik A; Balog J; Zidar J; Henderson D; Goselink R; Tapscott SJ; Voermans NC; Tawil R; Padberg GWAM; van Engelen BG; van der Maarel SM
J Med Genet; 2022 Feb; 59(2):180-188. PubMed ID: 33436523
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
